Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
JMDC Inc. ( (JP:4483) ) has issued an announcement.
JMDC Inc. reported significant financial growth for the first quarter ending June 30, 2025, with a 32.5% increase in revenue and a 48.8% rise in operating profit compared to the same period last year. This growth reflects the company’s strategic focus on its core operations after discontinuing its dispensing pharmacy support business, enhancing its market positioning and potentially increasing shareholder value.
The most recent analyst rating on (JP:4483) stock is a Buy with a Yen4800.00 price target. To see the full list of analyst forecasts on JMDC Inc. stock, see the JP:4483 Stock Forecast page.
More about JMDC Inc.
JMDC Inc. is a company listed on the Tokyo Stock Exchange, primarily involved in the healthcare industry. It focuses on providing data solutions and services that support the healthcare sector, including analytics and insights for medical institutions and pharmaceutical companies.
Average Trading Volume: 399,324
Technical Sentiment Signal: Buy
Current Market Cap: Yen261.4B
For an in-depth examination of 4483 stock, go to TipRanks’ Overview page.